Volume 13, Issue 2 (6-2025)
J Surg Trauma 2025, 13(2): 84-86 |
Back to browse issues page
Ahmad Amouzeshi 
, Mahmoud Ganjifard , Zahra Ansari Aval , Bibi Fatemeh Shakhs Emempour , Maryam Bahramian , Mozhgan Bahramian , Nafiseh Sadat Haerizadeh , Seyyed Ebrahim Hosseini Zargaz *
, Mahmoud Ganjifard , Zahra Ansari Aval , Bibi Fatemeh Shakhs Emempour , Maryam Bahramian , Mozhgan Bahramian , Nafiseh Sadat Haerizadeh , Seyyed Ebrahim Hosseini Zargaz *
Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
Abstract: (1270 Views)
The occurrence of cerebral embolic infarct following endocarditis is a complication that can lead to serious outcomes and mortality. The present case involves a patient with a history of intravenous drug use who developed multiple septic emboli and subsequent cerebral hemorrhage due to endocarditis. The patient was urgently scheduled for valve replacement surgery. Considering the patient's specific condition and history of hemorrhagic stroke, supportive measures during cardiopulmonary bypass were implemented without any specific complications, and the patient was discharged from the hospital after one week. Performing valve replacement surgeries in patients with a previous history of hemorrhagic stroke can be dangerous due to complications arising from anticoagulation, inflammatory responses, and changes in cerebral perfusion flow, potentially leading to death. However, these complications can be effectively mitigated with a series of supportive measures during cardiopulmonary bypass.
Type of Study: Case Report |
Subject:
Heart Surgery
Received: 2025/05/16 | Accepted: 2025/06/9 | ePublished ahead of print: 2025/06/17 | Published: 2025/06/17
Received: 2025/05/16 | Accepted: 2025/06/9 | ePublished ahead of print: 2025/06/17 | Published: 2025/06/17
References
1. Pham S, Heigle B, Gibbs C, Gebrehiwot WG, Pannu P. Complications of infective endocarditis: A case report of intracerebral hemorrhage exacerbated by enoxaparin. Cureus. 2024;16(5):e61235. [DOI:10.7759/cureus.61235]
2. Kesieme EB, Omoregbee B, Ngaage DL. A case report supporting early surgery in mitral valve infective endocarditis with recurrent cerebral infarcts. Eur Heart J Case Rep. 2024;8(12): ytae64. [DOI:10.1093/ehjcr/ytae641]
3. Amouzeshi A, Zargaz SE, Rezaei M, Riahi SM, Sa'adat F. The comparison of postoperative complications in hypothyroid and euthyroid patients undergoing cardiac surgery: A retrospective cohort study. Int Cardiovascu Res J. 2023;17(1):24-30.
4. Nappi F, Spadaccio C, Dreyfus J, Attias D, Acar C, Bando K. Mitral endocarditis: A new management framework. J Thorac Cardiovasc Surg. 2018;156(4):1486-95. [DOI:10.1016/j.jtcvs.2018.03.159]
5. Cartwright B, Mundell N. Anticoagulation for cardiopulmonary bypass: part one. BJA Educ. 2023;23(3):110-6. [DOI:10.1016/j.bjae.2022.12.003]
6. McKinley WI, Rowell SE, Mansour A, Hoefer L, Polcari A, Schreiber M, et al. Tranexamic acid, mortality, and intracranial hemorrhage type in moderate or severe traumatic brain injury. JAMA Surg. 2023;158(11):1222-4. [DOI:10.1001/jamasurg.2023.3848]
7. Hu W, Xin Y, Chen X, Song Z, He Z, Zhao Y. Tranexamic acid in cerebral hemorrhage: a meta-analysis and systematic review. CNS Drugs. 2019; 33:327-36. [DOI:10.1007/s40263-019-00608-4]
8. Xiong Y, Guo X, Huang X, Kang X, Zhou J, Chen C, et al. Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis. PLoS One. 2023;18(3):e0282726. [DOI:10.1371/journal.pone.0282726]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |